Researchers have identified a new method for analyzing chest CT scans that may help physicians better understand the different forms of sarcoidosis, a complex inflammatory lung disease that affects ...
A study found that in about 10 percent of patients, WGS picked up on clinically actionable information other panels missed.
Colorectal cancer may carry a unique microbial “fingerprint,” setting it apart from other cancers and opening a new frontier in diagnosis and treatment. By analyzing DNA from over 9,000 patients, ...
An analysis of lung screening data led by Brown University researchers helps identify which abnormalities detected outside ...
Abstract: The accurate diagnosis and personalized treatment of renal cancer are significant challenges due to its complexity and heterogeneity. Machine learning (ML) techniques have opened new avenues ...
The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social media. This growing trend has become an increasing concern for oncology ...
Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials Total ...
Researchers have detected microplastics in nearly all prostate cancer tumors examined in a new study. Tumor tissue contained about 2.5 times more plastic than nearby healthy prostate tissue.
Pooled trials show Pluvicto improves progression-free survival in advanced prostate cancer, without increasing serious adverse events. An examination of data from more than 2500 patients with advanced ...
The University of Louisville's Brown Cancer Center is the first U.S. medical facility to offer FDA-approved in-house solid tumor DNA testing. This new on-site technology reduces the wait time for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results